Figure 3 — Comprehensive evaluation of the efficacy and safety of LPV/r drugs in the treatment of SARS and MERS to provide potential treatment options for COVID-19

Navigate

Research Paper|Volume 13, Issue 8|pp. 10833–10852

Comprehensive evaluation of the efficacy and safety of LPV/r drugs in the treatment of SARS and MERS to provide potential treatment options for COVID-19

Back to articleFigure 3(3 of 11)

100%

Figure 3.Risk of bias summary.

Figure 3 — Comprehensive evaluation of the efficacy and safety of LPV/r drugs in the treatment of SARS and MERS to provide potential treatment options for COVID-19 | Aging